We studied 25 T-cell chronic lymphocytic leukemia (T-CLL) cases collec
ted over a 15-year period. Immunophenotypic analysis was performed in
each case; 12 cases were evaluated by cytogenetics, and gene rearrange
ment studies were performed in 14 cases. The median age was 57 years w
ith a male predominance (M:F, 15:10). The median presenting lymphocyte
count was 36.3 x 10(9)/L (range, 3.9 to 438 x 10(9)/ L). Fourteen pat
ients (56%) had shotty adenopathy and ten (40%) had mild-to-moderate s
plenomegaly at presentation; four (16%) had erythematous skin lesions.
The lymphocytes were predominantly small; some cases had a minor comp
onent of medium-sized cells (<10%). The nuclear:cytoplasmic ratios wer
e uniformly high with round to oval nuclei; however, a wide spectrum o
f nuclear outlines could be found, ranging from minimally to markedly
convoluted. Nucleoli were either absent or small and inconspicuous, Th
ese lymphocytes did not have the morphology of prolymphocytes and did
not contain cytoplasmic granules. Bone marrow infiltration was general
ly in an interstitial pattern; the degree of involvement ranged from 1
5% to 90%. Immunophenotyping showed that the lymphocytes were mature T
-cells with a predominant CD4(+) immunophenotype. Three cases displaye
d a CD8(+) immunophenotype. The patients were treated with a variety o
f chemotherapeutic regimens with only a minimal response observed in t
wo of 20 patients. We conclude that T-CLL is an uncommon chronic lymph
oproliferative disorder (CLPD) that can be morphologically similar to
B-CLL, is distinct from T-prolymphocytic leukemia, and has an aggressi
ve clinical course that is refractory to therapy. It may also be diffi
cult to distinguish T-CLL from other T-CLPD, especially the leukemic p
hase of peripheral T-cell lymphoma and some cases of Sezary syndrome.
(C) 1995 by The American Society of Hematology.